UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Looking for ways to generate cash today? Check out fast earning methods that can help you boost your income quickly.
22,309 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Spotify unveiled a long-term plan to hit 1 billion active users and sustain 20% operating margins by 2030, highlighti...
Two pharma giants are wighting for a leadership position in immunology. This piece explains why Johnson Johnson hopes...
The AI hype has lifted many stocks, but a bubble bursts scenario could knock the S&P 500 lower. This guide shows how ...
A space-focused Nasdaq-100 entrant is drawing attention after earnings and a key index promotion. Investors see a pot...
AI is reshaping business, and a few durable names stand to benefit for years. Here are three artificial intelligence ...
Bank of America Securities unveils four US Q3 ideas that fuse dividend income with double-digit upside potential. The...
Rising costs and higher rates are pressuring traditional bonds. More retirees replacing bond allocations with dividen...
When a top executive sells a large block of stock, investors want to know whether it signals trouble or simply person...
Salesforce stock faces a pivotal year as AI-enhanced CRM and cloud strategy shape the upside. Here's the latest marke...
Analysts are warming to a pair of fintech names as valuations cool and growth metrics improve. This report explains w...
The weight loss field is heating up, with Novo Nordisk leading the GLP-1 wave and Amgen pursuing a smaller, more sele...